You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lynparza

Showing 26 - 50 of 155
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer Trial in Shanghai (Cisplatin, Nab-paclitaxel, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

Advanced Gastric Adenocarcinoma Trial in Baltimore (Paclitaxel, Olaparib, Pembrolizumab)

Recruiting
  • Advanced Gastric Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 3, 2022

Ovarian Epithelial Cancer Trial in Leuven (Olaparib, carboplatin + gemcitabine or carboplatin + paclitaxel or carboplatin +

Active, not recruiting
  • Ovarian Epithelial Cancer
  • Olaparib
  • carboplatin + gemcitabine or carboplatin + paclitaxel or carboplatin + liposomal doxorubicin or liposomal doxorubicin 4-weekly or topotecan or paclitaxel weekly
  • Leuven, Belgium
    UZLeuven
Jan 26, 2021

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • (no location specified)
Aug 10, 2022

Pulmonary Arterial Hypertension Trial in Edmonton, Toronto, Quebec City (Olaparib)

Recruiting
  • Pulmonary Arterial Hypertension
  • Edmonton, Alberta, Canada
  • +2 more
May 25, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Laboratory Biomarker Analysis
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 19, 2022

Carcinoma, Ovarian Epithelial Trial in Hidaka (pembrolizumab, olaparib, bevacizumab)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • pembrolizumab
  • +5 more
  • Hidaka, Saitama, Japan
    Saitama Medical Uiversity International Medical Center
Apr 25, 2022

Prostate Cancer, Castration-resistant Prostate Cancer Trial in Washington, Baltimore (Olaparib, Vitamin C)

Not yet recruiting
  • Prostate Cancer
  • Castration-resistant Prostate Cancer
  • Washington, District of Columbia
  • +1 more
Aug 12, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Boston, Houston

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 12, 2023

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Durvalumab
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

Recruiting
  • High Grade Serous Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
  • +2 more
Nov 28, 2022

Advanced Ovarian Cancer Trial in Spain (Olaparib, Pegylated Liposomal Doxorubicin)

Completed
  • Advanced Ovarian Cancer
  • Sabadell, Barcelona, Spain
  • +7 more
Jan 25, 2023

Glioma, Cholangiocarcinoma, Solid Tumor Trial in Toronto (Olaparib, Durvalumab)

Recruiting
  • Glioma
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 29, 2021

Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Endometrial Serous Adenocarcinoma
  • +2 more
  • Biopsy
  • +3 more
  • Phoenix, Arizona
  • +3 more
Feb 2, 2023

Pancreatic Cancer Trial (Pembrolizumab, Olaparib)

Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
Oct 21, 2021

Non Small Cell Lung Cancer Trial in Newcastle Upon Tyne (Radiotherapy, Olaparib Oral Tablet [Lynparza], AZD1390)

Recruiting
  • Non Small Cell Lung Cancer
  • Radiotherapy
  • +5 more
  • Newcastle Upon Tyne, United Kingdom
    Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust
Sep 20, 2022

High Grade Serous Carcinoma Trial in Baltimore, Boston, Philadelphia (Olaparib Pill, AZD6738)

Recruiting
  • High Grade Serous Carcinoma
  • Baltimore, Maryland
  • +2 more
Mar 4, 2022

Epithelial Ovarian Cancer Trial in Mannheim, Essen, Hamburg (olaparib, durvalumab)

Recruiting
  • Epithelial Ovarian Cancer
  • Mannheim, Baden-Württemberg, Germany
  • +2 more
Jun 15, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Apr 8, 2023

Ovarian Cancer Trial in Manchester (Olaparib, Cediranib, Platinum-based Chemotherapy)

Completed
  • Ovarian Cancer
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Feb 4, 2022

Prostate Cancer, Prostate Carcinoma, Metastatic Prostate Cancer Trial (Olaparib tablet, Abiraterone acetate, Prednisone tablet)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Olaparib tablet
  • +2 more
  • (no location specified)
Dec 7, 2021

LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)

Recruiting
  • Pancreatic Neoplasms
    • Osaka, Lyn010001, Japan
    • +46 more
    Aug 4, 2022